��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
欣技(6160)
月營收
季盈餘
2025/02/01
26.65元 (欣技股價)
2025/02/01
-16.45%
(年增率)
82百萬元 (營收)
欣技(6160) 年度營收走勢圖
欣技(6160)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/02
82,290
-15.84%
98,490
-16.45%
180,063
4.69%
114/01
97,773
-23.97%
73,514
33.00%
97,773
33.00%
113/12
128,592
-0.15%
86,130
49.30%
1,294,440
-4.79%
113/11
128,779
-4.67%
107,933
19.31%
1,165,848
-8.45%
113/10
135,090
42.90%
110,470
22.29%
1,037,069
-11.02%
113/09
94,532
-8.63%
97,334
-2.88%
901,979
-14.51%
113/08
103,464
-21.95%
92,691
11.62%
807,447
-15.69%
113/07
132,563
54.40%
83,877
58.04%
703,983
-18.61%
113/06
85,855
-21.54%
105,184
-18.38%
571,420
-26.85%
113/05
109,421
22.93%
84,855
28.95%
485,565
-28.16%
113/04
89,013
-22.68%
124,403
-28.45%
376,144
-36.36%
113/03
115,127
16.89%
229,302
-49.79%
287,131
-38.47%
113/02
98,490
33.97%
129,788
-24.11%
172,004
-27.54%
113/01
73,514
-14.65%
107,582
-31.67%
73,514
-31.67%
112/12
86,130
-20.20%
121,510
-29.12%
1,359,549
8.08%
112/11
107,933
-2.30%
139,518
-22.64%
1,273,419
12.05%
112/10
110,470
13.50%
119,269
-7.38%
1,165,486
16.91%
112/09
97,334
5.01%
104,831
-7.15%
1,055,016
20.21%
112/08
92,691
10.51%
84,433
9.78%
957,682
23.92%
112/07
83,877
-20.26%
108,543
-22.72%
864,991
25.65%
112/06
105,184
23.96%
111,631
-5.78%
781,114
34.71%
112/05
84,855
-31.79%
112,059
-24.28%
675,930
44.36%
112/04
124,403
-45.75%
84,834
46.64%
591,075
65.95%
112/03
229,302
76.67%
110,240
108.00%
466,672
71.99%
112/02
129,788
20.64%
81,333
59.58%
237,370
47.35%
112/01
107,582
-11.46%
79,761
34.88%
107,582
34.88%
111/12
121,510
-12.91%
120,951
0.46%
1,257,962
-11.34%
111/11
139,518
16.98%
148,415
-5.99%
1,136,452
-12.44%
111/10
119,269
13.77%
140,398
-15.05%
996,934
-13.27%
111/09
104,831
24.16%
130,208
-19.49%
877,665
-13.03%
111/08
84,433
-22.21%
118,517
-28.76%
772,834
-12.07%
111/07
108,543
-2.77%
105,463
2.92%
688,401
-9.47%
111/06
111,631
-0.38%
122,318
-8.74%
579,858
-11.46%
111/05
112,059
32.09%
124,737
-10.16%
468,227
-12.09%
111/04
84,834
-23.05%
87,069
-2.57%
356,168
-12.68%
111/03
110,240
35.54%
121,722
-9.43%
271,334
-15.42%
111/02
81,333
1.97%
105,821
-23.14%
161,094
-19.08%
111/01
79,761
-34.06%
79,761
110/12
120,951
-18.50%
1,418,876
110/11
148,415
5.71%
1,297,925
110/10
140,398
7.83%
1,149,510
110/09
130,208
9.86%
1,009,112
110/08
118,517
12.38%
878,904
110/07
105,463
-13.78%
760,387
110/06
122,318
-1.94%
654,924
110/05
124,737
43.26%
532,606
110/04
87,069
-28.47%
407,869
110/03
121,722
15.03%
320,800
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
